Sign in
4

Changes in Ownership

Rein Therapeutics, Inc. Filed Acc 0000899243-17-018014

Director bought 273,333 shares at $15.00 ($4,099,995)

  • Director acquired 1,158,186 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Gallagher Brian M. Jr. · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-07-05 Conversion : show line 1 in the form +1,158,186 1,158,186 I
2017-07-05 Purchase : show line 2 in the form +273,333 $15.00 $4,099,995 1,431,519 I
Open-market purchases · 273,333 sh · avg $15.00 · $4,099,995

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2017-07-05 Conversion : show line 3 in the form Series D Preferred Stock −6,781,770 0 I
2017-07-05 Conversion : show line 4 in the form Series E-2 Preferred Stock −1,471,551 0 I
2017-07-05 Conversion : show line 5 in the form Series E-3 Preferred Stock −1,276,389 0 I
2017-07-05 Conversion : show line 6 in the form Series F Preferred Stock −1,979,188 0 I
Loading xslF345X03/doc4.xml…